CIPO Patents = 2

EPO Patents = 1

Forward Citations = 25

Loading Chart...

3 inventors (with patents filed for the assignee):

Basil M Hantash (15 out of 38 patents)

Anan Abu Ubeid (2 out of 2 patents)

Ying Wang (1 out of 3 patents)

15 patents: Sort by Forward Citations

1. 12415988 - Enhanced differentiation of mesenchymal stem cells (2025-09-16),

2. 12414978 - Tyrosine inhibitors with immunosuppressive activity in human neonatal keratinocyte progenitors (2025-09-16),

3. 12251402 - Mesenchymal stem cells with enhanced immunosuppressive capability (2025-03-18),

4. 10576105 - Mesenchymal stem cells with enhanced immunosuppressive capability (2020-03-03),

5. 10053670 - Enhanced differentiation of mesenchymal stem cells (2018-08-21),

6. 9714280 - HLA G-modified cells and methods (2017-07-25),

7. 9567368 - Peptide tyrosinase activators (2017-02-14),

8. 9554746 - System for evaluating skin treatment (2017-01-31),

9. 9382514 - Compositions comprising mesenchymal stem cell-derived fibroblasts (2016-07-05),

10. 9347045 - Differentiation of mesenchymal stem cells into fibroblasts (2016-05-24),

11. 9320698 - Peptide tyrosinase inhibitors and uses thereof (2016-04-26),

12. 9173904 - Method of cell transplantation into a human recipient (2015-11-03),

13. 8911723 - Hybrid hydrogel scaffold compositions and methods of use (2014-12-16),

14. 8822215 - Differentiation of mesenchymal stem cells into fibroblasts, compositions comprising mesenchymal stem cell-derived fibroblasts, and methods of using the same (2014-09-02),

15. 8647871 - Endogenous expression of HLA-G and/or HLA-E by mesenchymal cells (2014-02-11),

Company Overview

Escape Therapeutics, Inc. is a biotechnology company based in San Jose, California, focused on developing innovative therapies for neurological disorders. The company specializes in advanced drug delivery systems and therapeutic modalities aimed at addressing unmet medical needs in the treatment of conditions such as neurodegenerative diseases. By leveraging cutting-edge research and technology, Escape Therapeutics aims to enhance patient outcomes through targeted and effective treatment solutions.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

15 Patents

#418 in San Jose, CA

#5,027 in California

#21,052 in US

#39,921 in the World

San Jose, CA, United States of America

Escape Therapeutics, Inc.

Forward Citations = 25

3 inventors:

Basil M Hantash (15 out of 38 patents)

Anan Abu Ubeid (2 out of 2 patents)

Ying Wang (1 out of 3 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Escape Therapeutics, Inc.. Retrieved from https://idiyas.com/company/escape-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

2 patents (CIPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]